Document is current
Any future updates will be listed below
-
Authors
Fehr, Martin https://orcid.org/0000-0003-2128-9061
Naegele, Matthias https://orcid.org/0000-0003-3169-1812
Greiling, Michael https://orcid.org/0000-0002-3449-5123
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 9 August 2025
First Online: 6 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: MF is consultant hematologist and medical oncologist and the clinical lead of autologous cellular therapies at the Cantonal Hospital St. Gallen and the institution he is employed by has received consulting/advisory honoraria from Eli Lilly, Incyte, and Kite/Gilead, speaker honoraria from AbbVie, and travel support from Janssen, Takeda, and AbbVie. MN is clinical nurse specialist and has received honorarium for consultation and presentation from J&J Innovative Medicine. MG is the scientific director of software-based academic training with a university certificate for Certified Workflow Manager in Health Care with the ClipMedPPM application and was remunerated by J&J Innovative Medicine for this analysis. He also discloses connections to J&J Innovative Medicine EMEA in the form of a mandate to conduct a software-based procedural health economic analysis (SPHA).
